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Summary
Background: In eukaryotes, ribosome biosynthesis involves
the coordination of ribosomal RNA and ribosomal protein
(RP) production. In S. cerevisiae, the regulation of ribosome
biosynthesis occurs largely at the level of transcription. The
transcription factor Ifh1 binds at RP genes and promotes their
transcription when growth conditions are favorable. Although
Ifh1 recruitment to RP genes has been characterized, little is
known about the regulation of promoter-bound Ifh1.
Results: We used a novel whole-cell-extract screening
approach to identify Spt7, amember of the SAGA transcription
complex, and the RP transactivator Ifh1 as highly acetylated
nonhistone species. We report that Ifh1 is modified by acetyla-
tion specifically in an N-terminal domain. These acetylations
require the Gcn5 histone acetyltransferase and are reversed
by the sirtuin deacetylases Hst1 and Sir2. Ifh1 acetylation is
regulated by rapamycin treatment and stress and limits the
ability of Ifh1 to act as a transactivator at RP genes.
Conclusions: Our data suggest a novel mechanism of regula-
tion whereby Gcn5 functions to titrate the activity of Ifh1
following its recruitment to RP promoters to provide more
than an all-or-nothing mode of transcriptional regulation. We
provide insights into how the action of histone acetylation
machineries converges with nutrient-sensing pathways to
regulate important aspects of cell growth.
Introduction
Growth and cell division are tightly coupled such that cells
must reach a size threshold prior to irreversible commitment
to a new cell cycle [1]. Growth potential, in turn, depends
largely on the ability of a cell to increase its translational
capacity by synthesizing new ribosomes. In budding yeast,
a group of over 200 coregulated genes, termed the ribosome
biogenesis cluster, must coordinate the assembly of four
ribosomal RNA (rRNA) molecules transcribed by RNA pol I
and RNA pol III with 79 ribosomal proteins (RPs) whose
messenger RNAs (mRNAs) are transcribed by RNA pol II
from 138 open reading frames (ORFs) scattered throughout
the genome. This complex process of ribosome production
is coupled to nutrient availability and is downregulated at*Correspondence: toczyski@cc.ucsf.edumultiple levels both during starvation and under conditions
of cellular stress [1–4].
RP transcription accounts for up to 50% of all RNA pol II-
mediated transcription and is regulated in large part by the
essential transcriptional activator Ifh1 [5]. Ifh1 is recruited
almost exclusively to RP promoters. This recruitment is medi-
ated by an interaction with the fork-head-associated (FHA)
domain of Fhl1, which remains constitutively bound at pro-
moter sites [6–9]. Target of rapamycin (TOR) kinase activity
promotes Ifh1 recruitment when nutrients are available [6]. In
contrast, Ifh1 is not bound to RP promoters during periods
of starvation or stress [6–9]. Fhl1-dependent Ifh1 recruitment
is insufficient to drive transcription on its own [10], and other
factors, such as promoter-bound Rap1 or the transcription
factors Sfp1 and Hmo1, may function in a pathway required
for Ifh1 function [3, 10, 11].
Acetylation of lysine residues in histone tails modifies chro-
matin structure both directly, by neutralizing the positive
charge of these residues, and indirectly, by creating binding
sites for acetyllysine-binding bromodomains [12]. Protein
complexes recruited via acetyllysine-dependent interactions
may participate in chromatin remodeling by sliding or evicting
nucleosomes from DNA at promoters to provide access to
site-specific regulators of transcription [12]. Two histone ace-
tyltransferases (HATs) bind RP promoters. First, the essential
HAT Esa1 positively regulates RP transcription [13, 14]. This
regulation is thought to occur via acetylation of the N-terminal
tails of histone H4 and is opposed by the action of the Rpd3
deacetylase [13, 15]. Esa1 recruitment to RP promoters corre-
lates with favorable growth conditions and occurs in part
through a direct interaction with Rap1, which, like Fhl1, is a
constitutive resident at RP promoters [15, 16]. Chromatin
immunoprecipitation studies suggest that the SAGA complex,
which contains the Gcn5 HAT, also localizes to RP genes
[14, 17]. In contrast to Esa1, however, SAGA recruitment to
RP genes does not appear to be significantly regulated by
stress in logarithmically growing cultures [18] and the relevant
target(s) of Gcn5 at RP promoters are not fully understood.
Here, we provide new mechanistic insights into RP tran-
scriptional regulation by showing that Gcn5 acetylates the
Ifh1 transcription factor. Acetylation of Ifh1 occurs predomi-
nantly in an N-terminal acidic region and is negatively regu-
lated by the sirtuin class of deacetylases. Furthermore, we
find that acetylation is regulated by the TOR nutrient-sensing
kinase and cellular stress. Analysis of nonacetylatablemutants
suggests that Ifh1 acetylation negatively regulates its function
at RP promoters. We suggest a model whereby unacetylated
Ifh1 is recruited to promoters in response to nutrients and pro-
vides an initial burst of activity that is subsequently restrained
by Gcn5-mediated acetylation.
Results
Ifh1 and SAGA Subunits Are Highly Acetylated Proteins
in Yeast
Recent work suggests that yeast HATs may regulate cell func-
tion in part though the modification of nonhistone substrates
[19, 20]. To study nonhistone acetylation in yeast, we probed
Figure 1. SAGA Subunits and Ifh1 Are Acetylated Proteins in Yeast
(A) Western blots of yeast WCEs prepared from the indicated strains were
probed with anti-acetyllysine antibodies. An antibody against Cdc28 was
used as a loading control. Strains were incubated with or without 20 mM
nicotinamide treatment. The arrow indicates the position of an w200 kDa
species that is highly reactive with our anti-acetyllysine antibodies.
Numbers indicate molecular weight markers in kDa.
(B) A Gcn5-regulated band of high molecular weight is a composite of Spt7
and Ifh1. WCEs were prepared from the indicated GFP-tagged or wild-type
control strains and separated on a 4%–20% SDS-PAGE gel prior to western
blotting and detection of acetylated species using an anti-acetyllysine anti-
body.
(C) Western blotting was used to determine the acetylation status of GFP-
tagged proteins following their immunoprecipitation from cultures grown
with or without nicotinamide (20 mM). Smc3, a known acetylated protein,
is used as a control. Mbp1, an unrelated transcription factor, showed no
acetylation in this assay.
See also Figure S1.
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1639western blots of yeastwhole-cell extracts (WCEs) derived from
strains mutated for various histone acetyltransferases with
anti-acetyllysine antibodies. This analysis revealed a repro-
ducible pattern of reactive species that was similar for WCEs
from wild-type cells and most HAT mutants (Figure S1 avail-
able online). In contrast, extracts from gcn5D mutant cells
showed a striking absence of a number of highly reactive
species while having a total protein profile identical to that of
wild-type cells (Figures 1A, S1A, and S1B). We focused our
attention on a large (approximately 200 kDa molecular
weight) band that was more reactive with our anti-acetyllysine
antibodies following nicotinamide treatment, which inhibits
all five members of the sirtuin family of deacetylases ([21];
Figure 1A).
We devised a simple method to identify the protein(s)
contributing to this sirtuin-regulated species. We reasoned
that anti-acetyllysine antibody immunoblotting of WCE pre-
pared from a strain in which a large epitope tag was fused to
the immunoreactive protein would result in a banding patterndistinct from that of a wild-type strain in two ways. First, we
would observe a new acetylated species of increased
apparent molecular weight. Second, we would observe the
loss of an acetylated species corresponding to the untagged
protein’s size. We took advantage of a set of yeast strains in
which each ORF is expressed individually as a GFP-fusion
protein [22]. We carried out our WCE analysis for a subset
of these strains in which GFP was fused to ORFs with a pre-
dicted molecular weight of 120 kDa or higher. We found that
expression of GFP fusions with either Spt7 or Ifh1 caused a
change in the migration of thew200 kDa species on our blots,
suggesting that acetylation of both proteins contributes to the
overall signal observed in this single band (Figures 1B and
S1C). While the predicted molecular weight of each protein is
less than 200 kDa, both migrate anomalously on SDS-PAGE
gels for reasons that are not clear. To confirm that Spt7 and
Ifh1 are acetylated, we immunoprecipitated them from asyn-
chronously growing cultures in both the presence and
absence of the sirtuin inhibitor nicotinamide (Figure 1C). As a
positive control, we examined acetylation of the cohesin sub-
unit Smc3, a target of the Eco1HAT [23–25]. Both Ifh1 and Spt7
were highly reactive with anti-acetyllysine antibodies when
judged according to the amount of protein loaded (via anti-
GFP signal) and our Smc3 control (Figure 1C). In contrast, no
acetylation was observed on the transcription factor Mbp1
[26], a negative control, despite recovery of a significant
amount of target protein (Figure 1C). The acetylation of Ifh1,
but not that of Spt7 or Smc3, was dramatically increased in
the presence of nicotinamide, suggesting that Ifh1 might be
targeted by sirtuins (Figure 1C).
Since the acetylation of SAGA subunits byGcn5 has recently
been reported [17, 27], we focus here on the regulation and
function of Ifh1 acetylation. Since Ifh1 is a transcription factor,
we wondered whether other yeast transcription factors were
acetylated to the same degree following nicotinamide treat-
ment. Surprisingly, Ifh1 stood out in its strong reactivity with
anti-acetyllysine antibodies among more than 36 transcription
factors tested in immunoprecipitation (IP)-western experi-
ments (Figure 2; data not shown), suggesting that Ifh1 may
represent a particularly important nonhistone target for HATs.
Ifh1 Acetylation Is Regulated by a Subset of Sirtuins
S. cerevisiae encodes five sirtuins: Sir2 and Hst1–Hst4 [28].
Sir2, the eponymous founding member of the sirtuin class,
has roles in transcriptional silencing at subtelomeric regions,
the HM mating locus, and rDNA repeats in the nucleolus [12,
28–31]. Hst1 also functions in transcriptional regulation and
may functionally overlap with Sir2 in some contexts [28, 32].
Hst2 is the only cytoplasmic sirtuin, and its deletion causes
increased resistance to the translational inhibitor cyclohexi-
mide [33]. Finally, Hst3 and Hst4 act redundantly in deacetylat-
ing histone H3 K56 following DNA replication [34, 35]. As
shown in Figure 3A, we found that Ifh1 was highly acetylated
in an hst1D hst2D sir2D triple mutant compared to either
wild-type cells or cells treated with nicotinamide. Examination
of Ifh1 acetylation in strains lacking individual sirtuins sug-
gested that deacetylation is likely to be mediated mostly by
Sir2 and Hst1 (Figure 3B). The observation that Ifh1 acetylation
was greater in an hst1D hst2D sir2D strain than a wild-type
stain treated with nicotinamide suggested that sirtuins might
retain limited activity toward some substrates, even in high
concentrations of this drug. To determine if sirtuins act on
Ifh1 directly, we purified acetylated Ifh1 from hst1D hst2D
sir2D yeast and carried out in vitro deacetylation assays using
Figure 2. Nicotinamide Does Not Induce Global Acetylation of Transcription
Factors
The indicated GFP-tagged transcription factors were immunopurified from
log-phase cultures treated with nicotinamide (20 mM) using an aGFP anti-
body, and reactivity of recovered proteins with anti-acetyllysine antibodies
was tested following separation on 4%–20% SDS-PAGE gradient gels and
western blotting. Even when Ifh1 levels are adjusted to that of the lowest
abundant protein recovered, its acetylation stood out among all candidates
tested, which showed only background reactivity with our antibodies. The
asterisk indicates immunoglobulin G bands from immunoprecipitations.
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cofactor nicotinamide adenine dinucleotide (NAD+), and this
deacetylation was inhibited by inclusion of nicotinamide in
the reaction (Figure 3C). Together, our data suggest that Ifh1
is acetylated in vivo and that its acetylations are reversed by
a subset of sirtuins.
The Acetylation of Ifh1 Is Mediated by Gcn5
Esa1 has been previously implicated in the transcription of RP
genes through the regulation of histone H4 acetylation [13, 15].
To test for a role of Esa1 in Ifh1 acetylation, we immunoprecip-
itated Ifh1 from strains carrying the temperature-sensitive
esa1-414 allele [36] and examined acetylation of the recovered
protein. While global H4 acetylation was lost when esa1-414
strains were incubated at the restrictive temperature for 2 hr,
Ifh1 acetylation remained largely unaffected (Figure S2A).
These data suggest that Esa1 does not have a direct role in
acetylating Ifh1 at RP promoters. We also found that the dele-
tion of GCN4, which has been shown to inhibit Esa1 recruit-
ment to RP promoters [16], had no impact on Ifh1 acetylation
(Figure S2B).
Our initial screen suggested that Gcn5 may be required for
Ifh1 acetylation (Figure S1A). Indeed, Gcn5, with the SAGA
complex, localizes to RP promoters [14, 17]. In contrast to
protein from wild-type cells, Ifh1 from cells lacking GCN5
did not react with anti-acetyllysine antibodies (Figure 3D).
Gcn5 was also required for the increased acetylation of Ifh1
observed following treatment of cells with nicotinamide (Fig-
ure 3E). Gcn5 purified from bacteria, but not Gcn5-E173Q,
carrying a mutation in its catalytic domain [37], was able to
acetylate Ifh1 in vitro (Figure 3F), suggesting that Gcn5 acts
on Ifh1 directly. In vivo, however, Ifh1 acetylation required
the SAGA structural component Spt7, suggesting that SAGA
rather than free Gcn5 mediates Ifh1 acetylation in cells
(Figure 3G).
Ifh1 Acetylation Is Regulated by Nutrient Levels and
Temperature Stress
Since RP genes are regulated by stress and nutrient status [2],
we examined whether Ifh1 acetylation is also regulated under
such circumstances. We first tested the effect of rapamycin, a
TOR inhibitor that results in a rapid downregulation of RP gene
transcription [38]. As an independent measure of the efficacyof drug treatment, we monitored the status of Gln3-GFP
phosphorylation, which is dependent on TOR function and is
lost following rapamycin treatment [39]. Twenty minutes
after rapamycin treatment, Gln3 hyperphosphorylation was
decreased relative to a control treatment (Figure 4A, inputs).
The level of Ifh1 protein remained constant for both treated
and control cells for the course of the experiment (Figure 4A).
However, while Ifh1 acetylation also remained constant in
control cells, TOR inhibition immediately reduced this acetyla-
tion (Figure 4A). We also measured Ifh1 acetylation during a
mild temperature shock, which is associated with a temporary
downregulation of RP mRNA levels [40]. While Ifh1 levels
remained constant during a heat shock from 23C to 37C,
its acetylation rapidly decreased and remained low for
10–20 min before eventually recovering by 60 min (Figure 4B).
To determine if loss of Ifh1 acetylation after stress is due to the
action of sirtuins, we analyzed Ifh1 from cells treated simulta-
neously with both rapamycin and nicotinamide. Nicotinamide
had no effect on the loss of TOR-dependent Gln3 phosphory-
lation after rapamycin treatment (Figure 4C, inputs). However,
nicotinamide treatment prevented the rapid deacetylation of
Ifh1 observed in cells treatedwith rapamycin alone (Figure 4C),
suggesting that sirtuins are required for deacetylation of Ifh1
after stress.
The interaction of Ifh1 with promoter-bound Fhl1 is thought
to be a critical step in regulating the transcription of RP genes
and is assumed to be inhibited in growth conditions that allow
for only minimal RP transcription. Indeed, as reported previ-
ously [9], we found that the interaction of Ifh1 with Fhl1 was
abolished following treatment with rapamycin (Figure 4D).
Surprisingly, however, only limited reduction of the Fhl1-Ifh1
interaction was observed upon transfer of cells either to rich
media lacking any source of carbon or to water (Figures
S2C). We also found that the amount of Ifh1 bound to Fhl1
was virtually unchanged following the addition of glucose to
cells growing in a poor carbon source (Figure 4E). However,
in all cases, acetylation of Ifh1 was increased upon a return
to rich media (Figures 4E and S2C). These results suggest
that acetylation of promoter-bound Ifh1-Fhl1 molecules may
play a role in regulating RP transcription during a recovery
from stress.
Ifh1 is thought to be essential, due to both its importance in
activating RP transcription directly and its role in blocking
FHL1 repression of RP genes, such that an fhl1D is viable
and epistatic to ifh1D [41]. Rudra et al. previously reported
that Ifh1 could still interact with Rap1 in an fhl1 mutant strain
[42], despite the fact that Fhl1 seems to be required for
localization of Ifh1 to RP promoters by chromatin immunopre-
cipitation and for transcription from these promoters [9].
Accordingly, we found that Ifh1 was still acetylated in an
fhl1D strain, although this acetylation remained sensitive to ra-
pamycin and nicotinamide treatments (Figures 4F and S2D).
These data are consistent with a model wherein Ifh1 is loosely
bound at RP promoters in fhl1D strains in a manner that is
nonpermissive for DNA crosslinking while remaining amend-
able to acetylation by SAGA. They further suggest that addi-
tional protein contacts are required for Ifh1 recruitment and
function at RP promoters.
Ifh1 Is Acetylated at Multiple Lysine Residues in an
N-Terminal Domain
To identify the sites of Ifh1 acetylation in vivo, we purified flag-
tagged Ifh1 from sir2D hst1D hst2D cells (Figure 5A, top panel)
and identified acetylated lysine residues in peptides generated
Figure 3. Regulation of Ifh1 Acetylation
(A) Flag-tagged Ifh1 was immunoprecipitated from asynchronously growing cultures of the indicated genotypes and analyzed with an antibody directed
toward acetylated lysine or the flag epitope. Two isolates of the sirtuin triple mutant are shown.
(B) Flag-tagged Ifh1 was immunoprecipitated from asynchronously growing cultures of the indicated genotypes and analyzed as in (A).
(C) In vitro deacetylation of Ifh1. Partially purified GST-Sir2 was incubated with acetylated Ifh1 purified from sir2D hst1D hst2D cells under the reaction con-
ditions indicated for 1 hr at 30C. Reactionswere stoppedwith the addition of 33SDS-PAGE sample buffer and separated on a 4%–20%gradient gel prior to
western blotting and detection of acetyllysine using an anti-acetyllysine antibody. Nic, inclusion of 5 mM nicotinamide in the reaction as a sirtuin inhibitor.
(D) Gcn5 regulation of Ifh1 acetylation was examined using an IP-western protocol. The abundant Yap1 transcription factor was used to gauge general
cross-reactivity of the aAcK antibody.
(E) Gcn5 is required for the increased acetylation observed in nicotinamide-treated samples. Samples were processed as in (D), except that 33more IPed
material was loaded from slow-growing gcn5D strains relative to wild-type control strains to properly judge the level of acetylation.
(F) Gcn5 acetylation of Ifh1 in vitro. Bacterially purified Gcn5 or catalytic-deadmutant Gcn5 (Gcn5 E173Q) was incubatedwith Ifh1 purified from gcn5D yeast
under the reaction conditions specified for 1 hr at 30C. Reactions were stopped with the addition of 33 SDS-PAGE loading buffer and were separated on a
4%–20% gradient gel prior to western blotting and detection of reaction products with the indicated antibodies.
(G)Acetylation levelsof Ifh1 IPed fromwild-typeor spt7Dstrainswerecomparedusingananti-acetyllysineantibody followingSDS-PAGEandwesternblotting.
See also Figure S2.
Gcn5 Acetylation of Ifh1
1641by trypsin or chymotrypsin cleavage (see the Supplemental
Information). We identified seven acetylation sites of medium
or high confidence as judged by spectra quality and peptide
abundance (Figure 5A, bottom). Intriguingly, all seven of these
sites map to an acidic region in the N-terminal half of Ifh1 (Fig-
ure 5B). We tested the relative contribution of these sites tooverall Ifh1 acetylation by expressing mutant versions of these
proteins, in which identified sites are mutated to arginine,
which maintains the charge of a lysine residue but cannot be
acetylated, or to glutamine, which structurally mimics an
acetylated lysine residue. We found that mutation of lysines
180 and 254 to arginine severely diminished the level of Ifh1
Figure 4. Ifh1 Is Deacetylated following Cellular Stress
(A) Ifh1 acetylation was examined in asynchronously growing cultures treated with 200 ng/ml rapamycin or with vehicle control at the time points indicated.
The efficacy of rapamycin treatment was measured by examining loss of TOR-dependent Gln3-GFP phosphorylation in input material.
(B) Ifh1 acetylation during temperature shock. Logarithmically growing cultures were shifted from 23C to 37C, and acetylation of Ifh1 was assayed
following immunoprecipitation and western blotting.
(C) Sirtuin control of Ifh1 deacetylation following rapamycin treatment. Acetylation of Ifh1 was measured using an IP-western protocol from a strain treated
with 200 ng/ml rapamycin either with or without nicotinamide. Nicotinamide was added at the same time as rapamycin at a concentration of 65 mM.
(D) Ifh1 is acetylated when bound to Fhl1. Fhl1-3Flag was immunoprecipitated from log phase cells, cells treated with rapamycin (200 ng/ml for 40 min), or
with nicotinamide (65 mM for 40 min), and the recovered material was analyzed with the indicated antibodies following western blotting.
(E) Acetylation of Ifh1 associated with Fhl1 increases during recovery from carbon stress. Fhl1-3Flag was immunoprecipitated from cells after glucose addi-
tion to strains growing in glycerol-lactate media, and the recovered material was analyzed with the indicated antibodies after western blotting.
(F) Ifh1 acetylation was analyzed in wild-type or fhl1D strains with or without 200 ng/ml rapamycin treatment for 60 min.
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The observed signal was completely eliminated in a mutant
Ifh1 protein with all seven mapped lysine residues mutated,
whether they were changed to arginine or to glutamine (Fig-
ure 5C). A second independently generated antibody gave
almost identical results to the first, confirming that ourmapped
sites account for the majority of Ifh1 acetylation observed
in vivo (Figure 5C). Neither ifh1-7k-r nor ifh1-7k-qmutants dis-
played an obvious growth defect (data not shown), suggesting
that Ifh1 acetylation serves a regulatory role.Acetylation of Ifh1 Affects Its Activity as a Transactivator
Although Ifh1 is essential, simultaneous deletion of the gene
encoding its binding partner, Fhl1, rescues this lethality, pre-
sumably by alleviating a basal level of repression at RP pro-
moters [41]. Surprisingly, the level of RP transcripts compared
to other cellular mRNAs remained relatively unchanged in the
ifh1D fhl1D double mutant [9]. These data suggested the exis-
tence of feedbackmechanisms that adjust total transcriptional
output when RP transcription is compromised [9]. This and the
fact that RP transcription is regulated by many overlapping
Figure 5. Acetylation of Ifh1 Occurs in an N-Terminal Domain
(A) Flag-tagged Ifh1 was immunopurified from sir2D hst1D hst2D triple
mutant strains (top), and the recovered protein was trichloroacetic acid
precipitated and further purified using SDS-PAGE gel electrophoresis
prior to cleavage with trypsin or chymotrypsin and analysis by mass spec-
trometry. Potential Ifh1 acetylations were manually classified as high-,
medium-, or low-confidence sites based on spectra quality and abundance,
as determined by spectral counting (bottom).
(B) All high- and medium-confidence sites mapped to the N-terminal acidic
region of Ifh1.
(C) In vivo acetylation status of WT Ifh1, Ifh1 with lysines K180 and K254
mutated to arginine (ifh1-2k-r), or with lysines 9, 20, 26, 94, 95, 180, and
254 mutated to arginine or glutamine (ifh1-7k-r and ifh1-7k-q, respectively)
was determined following immunoprecipitation from asynchronously
growing cultures.
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translational modification at native RP promoters. Therefore,
we firstmade use of a system inwhich the contribution of acet-
ylation to Ifh1 transactivator function could be measured in
isolation.
We used a one-hybrid system, in which the Gal4-DNA-bind-
ing domain (GBD) was fused to the C terminus of Ifh1, Ifh1-7k-
r, or Ifh1-7k-q. In these strains, the GAL1 upstream activating
sequence (UAS) has the potential to drive expression of the
HIS3 gene, in addition to GAL1 itself, by recruiting Gal4-fusion
proteins ([43]; Figure 6A). In contrast to other reporter assays
used to study Ifh1 function [6–8, 44], our assay does not
employ overexpression of Ifh1 fusion proteins but insteadrelies on the expression of such constructs from the native
IFH1 promoter. Ifh1-, Ifh1-7k-r-, and Ifh1-7k-q-GBD constructs
were expressed at equal levels (Figure 6B), and strains in
which these fusions are expressed as the only source of Ifh1
grew similarly on synthetic complete media (Figure 6C, left
panel). In contrast, strains expressing GBD fusions with nona-
cetylatable Ifh1 (7k-r) showed significantly better growth than
those expressing fusions with wild-type Ifh1 or the 7k-q
mutant on plates lacking histidine, where expression of HIS3
was required for growth. To confirm these results, we
measured the mRNA produced from the GAL1 gene in our
one-hybrid system. In this assay, strains expressing the nona-
cetylatable Ifh1 mutant showed a significant increase in GAL1
transcripts compared to either wild-type or acetyl-mimic
Ifh1 fusion proteins (Figure 6D). When we expressed our
Ifh1-GBD constructs from centromere/autonomously repli-
cating sequence plasmids, we observed that all three con-
structs allowed for some growth in liquid media lacking
histidine. Under these conditions, we observed a clear trend,
with wild-type Ifh1-GBD constructs allowing for an inter-
mediate level of growth relative to Ifh1-7k-r and Ifh1-7k-q
fusions, which conferred faster and slower growth, respec-
tively (Figure 6E). These data suggest that acetylation inhibits
Ifh1 function.
Acetylation of Ifh1 Limits RP Transcription Immediately
after a Change in Carbon Source
To address the role of Ifh1 acetylation at native RP pro-
moters, we examined the mRNA levels of four RP genes
following addition of glucose to cells growing in acetate
and glycerol—a nonfermentable carbon source that allows
for only a slow rate of growth. By 5 min after glucose addition,
wild-type cells had increased RP mRNA levels by 30% (Fig-
ure 7A). Consistent with the increased transactivator activity
of ifh1-7k-r mutants observed in our reporter assays (Fig-
ure 6), the levels of RP mRNA increased by 70% in ifh1-7k-r
cells at this same 5 min time point (p = 0.002 for wild-type
[WT] versus mutant at t = 5 min; Figure 7A). Intriguingly,
mRNA appeared to largely equalize in the two strains toward
the end of the experiment (Figure 7A). These observations
suggest that strains eventually compensate for the initial
increase in transcription observed in ifh1-7k-r cells (see the
Discussion). In contrast, strains expressing the acetyl-
mimic—ifh1-7k-q—allele showed no significant increase in
mRNA levels over wild-type cells but instead showed a
decrease in mRNA levels at the 10 min time point (Figure S3A).
Treatment of cells with nicotinamide or deletion of GCN5 both
reduced RP transcription after a change in carbon source
(Figure S3B), likely due to their pleiotropic effects on a large
number of genes. Indeed, this result highlights the impor-
tance of examining the specific effects of these regulators
on individual targets. Our analysis of Ifh1 mutants suggests
that Gcn5 acetylation of Ifh1 in particular functions to restrict
the initial increase in RP transcription that accompanies a
switch to a more efficient carbon source and a faster rate
of growth.
Dynamics of Ifh1 Acetylation
In addition to its binding to Fhl1 at promoters, Ifh1 is amember
of the CURI complex, containing Rrp7, Utp22, and Casein
kinase II subunits [42]. CURI has been proposed to function
as a link between rRNA processing and RP transcription,
with free Ifh1 functioning to bind to the Rrp7 and Utp22 rRNA
processing factors to inhibit their activity [42]. As such, CURI
Figure 6. Ifh1 Acetylation Inhibits Its Transactivator Activity
(A) Experimental design. Ifh1 or the indicatedmutants were expressed under the Ifh1 promoter as fusion proteins with the GBD in a strain in which theGAL1
UAS drives transcription of the HIS3 gene in addition to endogenous GAL genes.
(B) Expression of Ifh1 fusion proteins in the strains described in (A). Myc-tagged GBD fusions are the only source of Ifh1 in these strains.
(C) Five-fold serial dilutions of strains expressing the indicated Ifh1 fusions on completemedia or completemedia lacking histidine (C-histidine). Plates were
imaged after 2 days’ growth at 30C.
(D) GAL1mRNA level (versus ACT1 control) in strains expressing the Ifh1 fusion proteins described in (A), as determined by quantitative PCR (qPCR) anal-
ysis. Error bars represent the SEM. The asterisk indicates significantly different fromWT (p < 0.03), with p values calculated using a two-tailed Student’s t test
(n = 4 for each strain type indicated).
(E) The indicated strains were grown to midlog phase in minimal media lacking tryptophan before being washed in water and transferred to media lacking
both tryptophan and histidine. Growth, which requires expression of the HIS3 gene, was assayed using OD 600 readings at the indicated time points. n = 3,
with error bars indicating the SEM.
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titrate both rRNA and RP production by regulating Ifh1 avail-
ability. We wondered whether CURI might play a role in the
acetylation-deacetylation cycle of Ifh1. We found that a signif-
icant fraction of the total acetylated Ifh1 in the cell is contained
within the CURI complex (Figure 7B). The acetylation of CURI-
bound Ifh1 was increased by nicotinamide treatment and
eliminated with rapamycin, and these effects could not beexplained by changes in Ifh1 binding to CURI (Figure 7B).
These data suggest the possibility that Ifh1 acetylated at the
promoter may subsequently accumulate in the CURI complex
for some period of time after its release. Interestingly, Ifh1
expressed from the strong TEF promoter did not result in an
increase in acetylated Ifh1, suggesting that overexpression
results in a large free pool of Ifh1 that is not targeted by
SAGA (Figure S3C).
Figure 7. Ifh1 Acetylation Regulates Native RP Transcription following a Change in Carbon Source
(A)Wild-type and ifh1-7k-r strains were grown in acetate/glycerol prior to the addition of glucose (t = 0). Samples were collected at the indicated time points,
and mRNA levels of the indicated RP genes were quantified, relative to levels of ACT1 mRNA, using qPCR. The mean and the SEM for seven independent
experiments are shown for each gene measured. The average percentage increase of RP mRNAs, relative to time zero, is shown for each strain at the indi-
cated time points.
(B) Acetylated Ifh1 accumulates within the CURI complex. Utp22-GFP was immunoprecipitated from log phase culture or from culture treated with rapa-
mycin (200 ng/ml) or nicotinamide (65 mM) for 40 min. Ifh1-3Flag was immunoprecipitated from a separate strain subjected to the same treatments to serve
as a control. Recovered material was analyzed with the indicated antibodies following western blotting.
(C) Model of Ifh1 function at RP promoters. (i) In poor carbon sources (e.g., glycerol), Ifh1 bound at RP promoters via an interaction with Rap1, Fhl1, and
possibly other proteins is inhibited directly or indirectly from promoting transcription by unknown factor(s) (protein ‘‘X’’) or through stress-induced changes
to overall promoter architecture. Gcn5-mediated acetylation of Ifh1 is inhibited by these same factors or is countered by sirtuin activity. (ii) With the addition
of glucose, repression of Ifh1 activity is relieved, resulting in increased transcription. The burst of transcription may function to jump-start ribosome biogen-
esis. (iii) Inhibition of sirtuin activity accompanying a switch to a better carbon source leads to an increase in Ifh1 acetylation. Acetylation inhibits Ifh1 trans-
activator function to control the rate with which RP transcripts accumulate to their maximal level. This regulation may serve as part of a broader mechanism
to allow for a tightly controlled response to a cell’s increased need for ribosome biogenesis.
See also Figure S3.
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HATs and histone deacetylases (HDACs) that bind to the pro-
moters of genes are often presumed to regulate transcription
through the modulation of histone acetylation. We have used
a WCE analysis technique to identify the Ifh1 transactivator
as a target of the Gcn5 HAT. We provide evidence that Gcn5
acetylation of Ifh1 inhibits its ability to act as a transcriptional
activator. We also find that rapamycin and heat shock rapidly
eliminate Ifh1 acetylation, likely via directed deacetylation by
Sir2. As ribosomal protein gene transcripts account for half
of the mRNA in the cell, even a minor disruption to RP tran-
scription caused by alterations to this acetylation-deacetyla-
tion cycle may have significant consequences for cellular
metabolism. While a role for sirtuins in metabolic regulation
is well documented, to our knowledge, our work is the first
to suggest a direct connection for these enzymes to the con-
trol of RP transcription.
Previous work has demonstrated that the TOR-dependent
interaction between Ifh1 and Fhl1 is of critical importance forRP transcription [6–9]. However, we found that the amount of
Ifh1 interacting with Fhl1 was unchanged following the addi-
tion of glucose to cells growing slowly in glycerol-lactate me-
dium, despite the observation that RP transcription increased
substantially under these same conditions (Figures 4E and 7A).
Moreover, the Ifh1-Fhl1 interaction was only moderately
reduced when cells growing in rich medium were transferred
to medium lacking any source of carbon or to water (Fig-
ure S2C). Alternative mechanism(s) must therefore exist to
prevent RP transcription under some stress conditions, and
these mechanisms must be overcome to allow for the burst
of RP transcription that accompanies a return to normal
growth once such stress is alleviated. Known RP regulators,
such as Sfp1, Hmo1, Rpd3, and Esa1, may be involved in regu-
lating the architecture of RP promoters—either to promote or
to inhibit transcription—during these transitional states, inde-
pendently of the Ifh1-Fhl1 interaction.
Our results suggest that Ifh1 acetylation increases as cells
recover from stress. Surprisingly, however, cells expressing
mutant Ifh1 that cannot be acetylated show increased
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suggesting an inhibitory role for Ifh1 acetylation. We propose
a model wherein promoter-bound and hypoacetylated Ifh1
could act as a strong transactivator to provide an initial burst
of RP transcription following recovery from stress or starva-
tion (Figure 7C). This rapid increase to transcriptional output
could jump-start ribosome biogenesis in the first minutes
following nutrient addition. Our data suggest that SAGA-
mediated acetylation of Ifh1 may normally function to limit
the strength of this burst of RP transcription. We found that
RP mRNA levels increased 70% 5 min after glucose addition
in the ifh1-7k-r mutant, as opposed to 30% in wild-type cells
(Figure 7A). Given that RP mRNAs account for up to half of
all RNA pol II-derived messages in the cell [5], this difference
amounts to a very large increase in total cellular mRNA
transcripts.
Despite a greater increase in RP transcription in ifh1-7k-r
mutants relative to wild-type controls early during carbon-shift
experiments, the levels of RP mRNAs were equalized in wild-
type and mutant ifh1 strains after 30 min (Figure 7A). This
equalization may involve a negative feedback mechanism trig-
gered by the initial burst of RP transcription and may function
by affecting RPpromoter architecture. Controlling the strength
and timing of the initial response to the addition of nutrients
may help cells to coordinate RP transcription with rRNA pro-
cessing and other growth-related processes.
How acetylation of Ifh1’s acidic domain might inhibit its
transactivator function is unclear. The transactivator do-
main(s) of Ifh1 have been proposed to reside in the C terminus
of the protein, although it is not obvious how these domains
function to promote RNA polymerase II recruitment and/or
activity [44]. Paradoxically, it has both been reported that
deletion of the N terminus of Ifh1 can dramatically increase
[44] or slightly decrease [6] transactivator activity of Ifh1 in
one-hybrid assays. The difference between these assays
appears to be whether Ifh1 was recruited to reporter genes
directly or indirectly via a GBD fusion with the Fhl1 FHA
domain. Moreover, a third study found that full-length Fhl1
fused to a DNA-binding domain was incapable of stimulating
transcription, even though this construct promoted Ifh1
recruitment [10]. These data suggest that Fhl1 may have a
regulatory role in RP transcription, in addition to its role in
initial Ifh1 recruitment. Acetylation in Ifh1’s acidic domain
may regulate this function. Acetylation may also alter Ifh1’s
interaction with other promoter-bound proteins, such as
Rap1. In this context, it is noteworthy that overexpression of
a construct containing an N-terminal Ifh1 fragment disrupts
Sir2-mediated telomere silencing, which also requires the
Rap1 protein [45].
Ifh1 within the CURI complex and Ifh1 bound to Fhl1 at RP
promoters are deacetylated after stress, and this deacetyla-
tion requires the action of sirtuins. While Sir2 and Hst2 have
been previously implicated in the deacetylation of two nonhis-
tone proteins, Pck1 [19] and Snf2 [46], respectively, Ifh1 is, to
our knowledge, the first such protein known to be regulated
redundantly by multiple yeast sirtuins. Purified Hst1 was not
active against acetylated Ifh1 in our in vitro reactions, although
also it appears to act as a poor enzyme in vitro on histone sub-
strates [47]. Hst1-mediated Ifh1 deacetylation may be facili-
tated in vivo by additional factors, or Hst1 may regulate Ifh1
acetylation indirectly.
During carbon starvation, most Ifh1 localizes to the nucle-
olus [3], where Sir2 and Hst1 have been shown to function
[28]. Since the bulk of Ifh1 appears to be bound within theCURI complex [42], it is tempting to speculate that relocaliza-
tion of CURI to the nucleolus may facilitate Ifh1 deacetylation.
The accumulation of hypoacetylated Ifh1 at RP promoters in
particular may also be facilitated by the inhibition of Gcn5 ac-
tivity toward Ifh1. Although significant changes in the recruit-
ment of the SAGA complex to RP promoters have not been
described for logarithmically growing cells, even following
stresses, such as heat shock [18], the inhibition of Gcn5’s
action on Ifh1 could result from the same mechanisms that
prevent transcription in the presence of Fhl1-bound Ifh1 mole-
cules. Deacetylation of Ifh1 may reset its ability to act as a
strong activator once starvation or stress conditions are
relieved.
Experimental Procedures
Details regarding specific experiments are contained in the Supplemental
Information.
Yeast Strains, Plasmids, and Growth Conditions
Yeast strains and plasmids were generated using standard techniques and
are described in Tables S1 and S2 and the Supplemental Experimental
Procedures.
Immunoprecipitations
Cells were lysed using a bead-beating protocol, and WCEs were clarified
via centrifugation at 4C (see the Supplemental Experimental Procedures
for specific conditions). Immunoprecipitations were carried out in volumes
of 500 ml with 0.5 ml of AB290 anti-GFP antibody for 2 hr. Proteins were
then recovered with 20 ml Protein A beads (Dynabeads, Invitrogen) for
40 min. For anti-Flag purifications, magnetic anti-Flag M2 beads (Sigma)
were used for 2 hr. Beads were washed with lysis buffer three times and
protein complexes were eluted in 60 ml SDS-PAGE sample buffer with
0.1 M dithiothreitol (DTT) at 65C for 10 min. Eluates were boiled prior to
SDS-PAGE.
HAT Assays
HAT assays were carried out in a final volume of 50 ml with 3 ml of 6His-TRX-
Gcn5 or 6His-TRX-Gcn5-E173Q (approximately 3 mg), 800 mM acetyl coen-
zyme A, and 25 ml 2X HAT buffer (100 mM NaCl, 10% glycerol, 100 mM
Tris-HCl pH 8.0, and 0.2 mM EDTA supplemented with 2 mM sodium buty-
rate and 2 mM DTT). Ifh1-3flag protein was purified from gcn5D yeast.
Reactions were carried out at 30C for 1 hr, stopped with the addition of
33 SDS-PAGE sample buffer containing 0.1M DTT, and boiled prior to
SDS-PAGE.
HDAC Assays
Ifh1 purified from hst1D hst2D sir2D cells was used in a final volume of 25 ml
with 5 ml 5X HDAC reaction buffer (250mMTris HCl, pH 8.0, 2.5mMDTT, one
Roche Protease inhibitor tablet without EDTA per 10 ml), 10 ml GST-Sir2
(approximately 0.5 mg total), and 100 mM NAD. Nicotinamide was used at
a final concentration of 5 mM. Reactions were incubated for 1 hr at 30C.
Reactions were stopped with the addition of SDS-PAGE sample buffer
with 0.1 M DTT and boiled to remove Ifh1 from beads.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and two tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.06.050.
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